What sector does Cadrenal Therapeutics Inc. Common Stock (CVKD) operate in?
Cadrenal Therapeutics Inc. Common Stock belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Cadrenal Therapeutics Inc. Common Stock (CVKD) current stock price?
As of the latest data, Cadrenal Therapeutics Inc. Common Stock stock price is $5.54, with a previous close of $5.42. Cadrenal Therapeutics Inc. Common Stock gained $0.12 in the last trading session, representing a 2.12% increase.
What is Cadrenal Therapeutics Inc. Common Stock (CVKD) current market capitalization?
Cadrenal Therapeutics Inc. Common Stock market cap is approximately 12.94 million.
What is Cadrenal Therapeutics Inc. Common Stock (CVKD) Earnings Per Share (EPS)?
The trailing EPS is -$8.72, and the forward EPS is -$4.99.
What is Cadrenal Therapeutics Inc. Common Stock (CVKD) EBITDA?
Cadrenal Therapeutics Inc. Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.69 million.
Does Cadrenal Therapeutics Inc. Common Stock (CVKD) pay dividends?
No. Cadrenal Therapeutics Inc. Common Stock does not pay a dividend.
What is Cadrenal Therapeutics Inc. Common Stock (CVKD) beta (volatility) score?
Cadrenal Therapeutics Inc. Common Stock has a beta of 1.213, suggesting it is more volatile than the market.